McLaughlin, Lily A.
Yildirim, Onur
Rosenblum, Marc K.
Imber, Brandon S.
Haseltine, Justin M.
Zelefsky, Michael J.
Schöder, Heiko
Morris, Michael J.
Rafelson, William M.
Krebs, Simone
Moss, Nelson S. https://orcid.org/0000-0002-0930-1681
Funding for this research was provided by:
NIH/NCI cancer center grant (P30 CA008748)
Article History
Received: 3 May 2023
Accepted: 24 May 2023
First Online: 29 May 2023
Declarations
:
: The authors of this research deny any conflicts of interest regarding this study and make the following disclosures: NSM: consulting fees for advisory board participation at AstraZeneca; MJZ: research grant funding from Novartis.